NIHR CLAHRC North Thames
Atrial Fibrillation (AF) is common at older ages affecting 1 in 8 people over age 75 and this is a major cause of stroke and heart disease. Appropriate anticoagulation combined with control of blood pressure and other risk factors is highly effective in reducing stroke and heart disease. However, for many people with AF treatment is less than optimal with wide variation between providers. This study aims to identify reasons for variation in management between GP Commissioning Groups and ways to improve this. We also consider whether routine pulse checks identify more cases of AF.
Dr John Robson, Clinical Effectiveness Group, Centre for Primary Care and Public Health, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary , University of London. Email: email@example.com
Zaheer Ahmed, Informatics Lead, Clinical Effectiveness Group. Email: firstname.lastname@example.org
Kate Homer, Research Assistant, Clinical Effectiveness Group. Email: email@example.com
Dr Jim Cole, Honorary Clinical Research Associate, Clinical Effectiveness Group. Email: firstname.lastname@example.org
Pyam Torabi, Honorary Clinical Research Associate, Clinical Effectiveness Group.
Dr Manil Malawana, NIHR-In Practice Fellow, Clinical Effectiveness Group. Email: email@example.com
Dr Kambiz Boomla, Clinical Lead, Clinical Effectiveness Group. Email: firstname.lastname@example.org
Report to be produced 2018